HCA Healthcare Inc. (HCA)
Here's Why HCA Healthcare (HCA) is a Strong Growth Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
HCA Healthcare, Inc. (HCA) Q4 2025 Earnings Call Transcript
HCA Healthcare, Inc. (HCA) Q4 2025 Earnings Call Transcript
HCA Healthcare Q4 Earnings Beat Estimates on Strong Patient Volumes
HCA's Q4 EPS surge 28.8% year over year to $8.01, beating estimates on strong patient volumes and higher revenue per equivalent admission.
Here's What Key Metrics Tell Us About HCA (HCA) Q4 Earnings
The headline numbers for HCA (HCA) give insight into how the company performed in the quarter ended December 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
HCA Healthcare (HCA) Beats Q4 Earnings Estimates
HCA Healthcare (HCA) came out with quarterly earnings of $8.01 per share, beating the Zacks Consensus Estimate of $7.36 per share. This compares to earnings of $6.22 per share a year ago.
HCA Healthcare forecasts 2026 profit above estimates on medical care services demand
HCA Healthcare on Tuesday forecast its profit for 2026 above Wall Street estimates as it expects lower costs and robust demand for its medical care services.
Countdown to HCA (HCA) Q4 Earnings: Wall Street Forecasts for Key Metrics
Looking beyond Wall Street's top-and-bottom-line estimate forecasts for HCA (HCA), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended December 2025.
Can HCA Q4 Earnings Withstand Higher Costs & Lower Outpatient Cases?
HCA Healthcare heads into Q4 earnings with solid admission and revenue growth, but rising costs and declining outpatient surgery cases cloud the odds of a beat.
HCA Healthcare (HCA) is a Top-Ranked Value Stock: Should You Buy?
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Why HCA Healthcare (HCA) is a Top Growth Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
HCA Healthcare Is Caring For Patients And Investors Alike
HCA Healthcare remains undervalued despite strong YTD outperformance, supported by robust profit and cash flow growth. HCA is positioned to benefit from an aging U.S. population, expanding hospital capacity, and leading market share in acute care services. Current valuation implies zero profit growth, yet HCA has consistently grown NOPAT 7%+ annually since 2007 and offers 40%+ upside with consensus growth.
Here's Why HCA Healthcare (HCA) is a Strong Value Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
